Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Zijlstra

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Journal of Diabetes Science and Technology|April 6, 2018
Analysis of "Laboratory and Benchtop Performance of a Mealtime Insulin Delivery System"Eric Zijlstra
Journal of Diabetes Science and Technology|May 31, 2014
Oral insulin reloaded: a structured approachEric Zijlstra, Lutz Heinemann, Leona Plum-Mörschel
Journal of Diabetes Science and Technology|September 9, 2016
A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic RangeEric Zijlstra, Lutz Heinemann, Annelie Fischer, et al.
Diabetes, Obesity & Metabolism|October 7, 2016
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trialTim Heise, Eric Zijlstra, Leszek Nosek, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Impact of Injection Speed, Volume, and Site on Pain SensationEric Zijlstra, Johannes Jahnke, Annelie Fischer, et al.
Journal of Diabetes Science and Technology|September 19, 2017
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 DiabetesEric Zijlstra, Marek Demissie, Tina Graungaard, et al.
Diabetes, Obesity & Metabolism|June 22, 2016
Euglycaemic glucose clamp: what it can and cannot do, and how to do itTim Heise, Eric Zijlstra, Leszek Nosek, et al.
Diabetes Care|February 27, 2010
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetesChristoph Kapitza, Eric Zijlstra, Lutz Heinemann, et al.
The Lancet. Diabetes & Endocrinology|January 26, 2019
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trialInge B Halberg, Karsten Lyby, Karsten Wassermann, et al.
Clinical Pharmacokinetics|May 17, 2019
The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male SubjectsInge B Halberg, Karsten Lyby, Karsten Wassermann, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Journal of Diabetes Science and Technology|April 6, 2018
Analysis of "Laboratory and Benchtop Performance of a Mealtime Insulin Delivery System"Eric Zijlstra
Journal of Diabetes Science and Technology|May 31, 2014
Oral insulin reloaded: a structured approachEric Zijlstra, Lutz Heinemann, Leona Plum-Mörschel
Journal of Diabetes Science and Technology|September 9, 2016
A Comprehensive Performance Evaluation of Five Blood Glucose Systems in the Hypo-, Eu-, and Hyperglycemic RangeEric Zijlstra, Lutz Heinemann, Annelie Fischer, et al.
Diabetes, Obesity & Metabolism|October 7, 2016
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trialTim Heise, Eric Zijlstra, Leszek Nosek, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Impact of Injection Speed, Volume, and Site on Pain SensationEric Zijlstra, Johannes Jahnke, Annelie Fischer, et al.
Journal of Diabetes Science and Technology|September 19, 2017
Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 DiabetesEric Zijlstra, Marek Demissie, Tina Graungaard, et al.
Diabetes, Obesity & Metabolism|June 22, 2016
Euglycaemic glucose clamp: what it can and cannot do, and how to do itTim Heise, Eric Zijlstra, Leszek Nosek, et al.
Diabetes Care|February 27, 2010
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetesChristoph Kapitza, Eric Zijlstra, Lutz Heinemann, et al.
The Lancet. Diabetes & Endocrinology|January 26, 2019
Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trialInge B Halberg, Karsten Lyby, Karsten Wassermann, et al.
Clinical Pharmacokinetics|May 17, 2019
The Effect of Food Intake on the Pharmacokinetics of Oral Basal Insulin: A Randomised Crossover Trial in Healthy Male SubjectsInge B Halberg, Karsten Lyby, Karsten Wassermann, et al.
Pageof 3